Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 61–72 of 76 articles · Understand the science
- Understand the science
Why a Computer Model Is Only a Starting Point for Pinealon Mechanism Claims
Pinealon is a three-amino-acid peptide also called EDR. An older primary study modeled possible interactions of EDR with DNA as part of a larger investigation involving nerve cell structures.
Pinealon1 source (2021)
- Understand the science
What a Receptor Structure Can Explain About PT-141
Bremelanotide, also called PT-141, is a cyclic peptide in the melanocortin research family. The current US label describes it as a melanocortin receptor agonist.
PT-1412 sources (2021, 2026)
- Understand the science
How two retatrutide trials counted breathing interruptions during sleep
Retatrutide is an investigational peptide that activates the GIP, GLP-1 and glucagon receptors. “RETA GLP-3” is a catalog label. Its number does not name a receptor target. A 2026 report examined retatrutide in adults with moderate to severe obstructive sleep apnea.
RETA GLP-33 sources (2025, 2026)
- Understand the science
What growth-factor binding proteins change in a laboratory experiment
Retatrutide activates GIP, GLP-1 and glucagon receptors and remains investigational. IGF-1 LR3 is a modified, extended form of insulin-like growth factor 1. An older experiment in cultured ovarian support cells shows why the modified form is treated as its own research material.
RETA / IGF-1 LR32 sources (1992, 2026)
- Understand the science
Why a releasing signal produced different growth hormone responses after radiation
Sermorelin is the amidated first 29 residues of growth hormone–releasing hormone (GHRH), prepared as a synthetic peptide.
Sermorelin2 sources (1999, 2013)
- Understand the science
How chemists used SLU-PP-332 to design related compounds
SLU-PP-332 is a small nonpeptide molecule that activates estrogen-related receptors, or ERRs. A 2026 study used its chemical structure as a starting point and asked which changes affected receptor signaling and properties such as solubility.
SLU-PP-3321 source (2026)
- Understand the science
What ERR activation changed in a mouse heart failure model
SLU-PP-332 is a nonpeptide small molecule designed to activate estrogen-related receptors. An older animal experiment asked whether it and a separate compound, SLU-PP-915, changed heart function in mice subjected to an increased pressure load.
SLU-PP-3321 source (2023)
- Understand the science
How SYNCHRONIZE-1 counted average weight change and response rates
Survodutide is an investigational peptide that activates GLP-1 and glucagon receptors. SYNCHRONIZE-1 tested it in adults with obesity or overweight and a related complication who did not have diabetes.
Survodutide1 source (2026)
- Understand the science
How a laboratory identified the acetylated fragment
TB-500 can refer to a short acetylated fragment of thymosin beta-4. The name became associated with that identity in part through an older 2012 study of a product sold under the name. The scientists used high-resolution mass spectrometry to examine the material.
TB-5001 source (2012)
- Understand the science
How to read a human eye trial cited alongside TB-500
TB-500 generally refers to an acetylated seven-amino-acid fragment related to thymosin beta-4. An older human trial often discussed in the same research area investigated a specific eye formulation, RGN-259, whose active substance was synthetic full-length thymosin beta-4.
TB-5002 sources (2012, 2015)
- Understand the science
How a 2026 Study Linked Thymosin Alpha 1 to Immune Recognition in Mice
Thymosin alpha-1 is a peptide studied for effects on immunity. A 2026 study by Yiting Wei and colleagues examined why certain immune responses to tumors were weak after chemotherapy. The paper combined observations from human samples with experiments in cells and mice.
Thymosin Alpha-11 source (2026)
- Understand the science
How a pragmatic trial studies tirzepatide in everyday care
Tirzepatide is a GIP and GLP-1 receptor agonist peptide. The “GLP-2” in this catalog label does not identify a receptor it activates. In 2026, the SURMOUNT-REAL UK investigators published a plan to assess how offering tirzepatide would affect outcomes in a routine primary care setting.
TIRZ GLP-22 sources (2022, 2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
